Table 1.
Antibody screening (indirect immunofluorescence)
| Test | Associated receptor/syndrome |
|---|---|
| NMDA-R | NMDA-R |
| Anti-VGKC | VGKC |
| Anti-Hu | Neuronal nucleus (paraneoplastic encephalomyelitis) |
| Anti-Ri | Paraneoplastic encephalomyelitis |
| Anti-Yo | Purkinje cell antibody |
| Anti-PCA-2 | PCA-2 |
| Anti-CV2/CRMP5 | CRMP5 |
| Anti-Ma/Ta | Limbic encephalitis |
| Anti-GAD | Anti- GAD |
| Anti-amphiphysin | Paraneoplastic/stiff person syndromes |
NMDA-R – N-methyl-D-aspartate receptor; VGKCL – Voltage-gated potassium channel; PCA-2 – Purkinje cell cytoplasmic autoantibody Type 2; CRMP5 – Collapsin response-mediator protein-5; GAD – Glutamic acid decarboxylase